SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-005267
Filing Date
2019-04-15
Accepted
2019-04-15 06:15:08
Documents
67
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 851360
2 img_3.jpg GRAPHIC 56638
3 img_4.jpg GRAPHIC 12743
4 ex31-1.htm EX-31.1 12327
5 ex32-1.htm EX-32.1 6650
  Complete submission text file 0001493152-19-005267.txt   5080101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE endv-20181231.xml EX-101.INS 912263
7 XBRL SCHEMA FILE endv-20181231.xsd EX-101.SCH 63308
8 XBRL CALCULATION FILE endv-20181231_cal.xml EX-101.CAL 59900
9 XBRL DEFINITION FILE endv-20181231_def.xml EX-101.DEF 245246
10 XBRL LABEL FILE endv-20181231_lab.xml EX-101.LAB 448974
11 XBRL PRESENTATION FILE endv-20181231_pre.xml EX-101.PRE 340878
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55453 | Film No.: 19747534
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1